Localized pmrB hypermutation drives the evolution of colistin heteroresistance
- PMID: 35675785
- PMCID: PMC9189680
- DOI: 10.1016/j.celrep.2022.110929
Localized pmrB hypermutation drives the evolution of colistin heteroresistance
Abstract
Colistin has emerged as an important last line of defense for the treatment of infections caused by antibiotic-resistant gram-negative pathogens, but colistin resistance remains poorly understood. Here, we investigate the responses of ≈1,000 populations of a multi-drug-resistant (MDR) strain of P. aeruginosa to a high dose of colistin. Colistin exposure causes rapid cell death, but some populations eventually recover due to the growth of sub-populations of heteroresistant cells. Heteroresistance is unstable, and resistance is rapidly lost under culture in colistin-free medium. The evolution of heteroresistance is primarily driven by selection for heteroresistance at two hotspot sites in the PmrAB regulatory system. Localized hypermutation of pmrB generates colistin resistance at 103-104 times the background resistance mutation rate (≈2 × 10-5 per cell division). PmrAB provides resistance to antimicrobial peptides that are involved in host immunity, suggesting that this pathogen may have evolved a highly mutable pmrB as an adaptation to host immunity.
Keywords: AMR; CP: Microbiology; Pseudomonas aeruginosa; antibiotic resistance; colistin; evolutionary rescue; experimental evolution; heteroresistance; hypermutability; mutation rate.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures
Similar articles
-
Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00556-19. doi: 10.1128/AAC.00556-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31383654 Free PMC article.
-
PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.Antimicrob Agents Chemother. 2012 Feb;56(2):1019-30. doi: 10.1128/AAC.05829-11. Epub 2011 Nov 21. Antimicrob Agents Chemother. 2012. PMID: 22106224 Free PMC article.
-
Colistin Heteroresistance and Involvement of the PmrAB Regulatory System in Acinetobacter baumannii.Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00788-18. doi: 10.1128/AAC.00788-18. Print 2018 Sep. Antimicrob Agents Chemother. 2018. PMID: 29914966 Free PMC article.
-
Regulating polymyxin resistance in Gram-negative bacteria: roles of two-component systems PhoPQ and PmrAB.Future Microbiol. 2020 Apr;15(6):445-459. doi: 10.2217/fmb-2019-0322. Epub 2020 Apr 6. Future Microbiol. 2020. PMID: 32250173 Free PMC article. Review.
-
Mechanisms and Clinical Relevance of Pseudomonas aeruginosa Heteroresistance.Surg Infect (Larchmt). 2023 Feb;24(1):27-38. doi: 10.1089/sur.2022.349. Epub 2023 Jan 9. Surg Infect (Larchmt). 2023. PMID: 36622941 Review.
Cited by
-
Mutational hotspots lead to robust but suboptimal adaptive outcomes in certain environments.Microbiology (Reading). 2023 Oct;169(10):001395. doi: 10.1099/mic.0.001395. Microbiology (Reading). 2023. PMID: 37815519 Free PMC article.
-
The evolution of colistin resistance increases bacterial resistance to host antimicrobial peptides and virulence.Elife. 2023 Apr 25;12:e84395. doi: 10.7554/eLife.84395. Elife. 2023. PMID: 37094804 Free PMC article.
-
Optimized Dosing and Delivery of Bacteriophage Therapy for Wound Infections.bioRxiv [Preprint]. 2024 Aug 25:2024.05.07.593005. doi: 10.1101/2024.05.07.593005. bioRxiv. 2024. PMID: 38766200 Free PMC article. Preprint.
-
Pre-existing chromosomal polymorphisms in pathogenic E. coli potentiate the evolution of resistance to a last-resort antibiotic.Elife. 2022 Aug 9;11:e78834. doi: 10.7554/eLife.78834. Elife. 2022. PMID: 35943060 Free PMC article.
-
Recent advances in therapeutic targets identification and development of treatment strategies towards Pseudomonas aeruginosa infections.BMC Microbiol. 2023 Mar 30;23(1):86. doi: 10.1186/s12866-023-02832-x. BMC Microbiol. 2023. PMID: 36991325 Free PMC article. Review.
References
-
- Baldi D.L., Higginson E.E., Hocking D.M., Praszkier J., Cavaliere R., James C.E., Bennett-Wood V., Azzopardi K.I., Turnbull L., Lithgow T., et al. The type II secretion system and its ubiquitous lipoprotein substrate, SslE, are required for biofilm formation and virulence of enteropathogenic Escherichia coli. Infect. Immun. 2012;80:2042–2052. doi: 10.1128/IAI.06160-11. - DOI - PMC - PubMed
-
- Barrick J.E., Colburn G., Deatherage D.E., Traverse C.C., Strand M.D., Borges J.J., Knoester D.B., Reba A., Meyer A.G. Identifying structural variation in haploid microbial genomes from short-read resequencing data using breseq. BMC Genomics. 2014;15:1039. doi: 10.1186/1471-2164-15-1039. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
